Gastric atrophy reversible or irreversible after helicobacter pylori eradication - An open question

Digestion

Volumn 83, Issue 4, 2011, Pages 250-252

  Malfertheiner, Peter ^a  

^a OTTO VON GUERICKE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOGENESIS; CHRONIC GASTRITIS; DISEASE COURSE; EDITORIAL; ERADICATION THERAPY; FOLLOW UP; HELICOBACTER INFECTION; HUMAN; INTESTINE METAPLASIA; NONHUMAN; PRIORITY JOURNAL; RISK ASSESSMENT; STOMACH ATROPHY; STOMACH CANCER; STOMACH DISEASE; STOMACH MUCOSA;

GASTRITIS, ATROPHIC; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INTESTINES; METAPLASIA; TREATMENT OUTCOME;

EID: 79151483491     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321529     Document Type: Editorial

References (23)

1. Meining A, Morgner A, Miehlke S, Bayerdörffer E, Stolte M: Atrophy-metaplasiadysplasia- carcinoma sequence in the stomach: a reality or merely an hypothesis? Best Pract Res Clin Gastroenterol 2001; 15: 983-998. (Pubitemid 34110604)
2. Wong BC, Lam SK, Wong WM, Chen JS, Zheng TT, Feng RE, Lai KC, Hu WH, Yuen ST, Leung SY, Fong DY, Ho J, Ching CK, Chen JS, China Gastric Cancer Study Group: Helicobacter pylori eradication to prevent gastric cancer in a high-risk region of China: a randomized controlled trial. JAMA 2004; 291: 187-194. (Pubitemid 38082812)
3. Walker MM: Is intestinal metaplasia of the stomach reversible? Gut 2003; 52: 1-4. (Pubitemid 36020750)
4. Correa P: A human model of gastric carcinogenesis. Cancer Res 1988; 1,48: 3554-3560.
5. Valle J, Seppala K, Sipponen P, Kosunen T: Disappearance of gastritis after eradication of H. pylori . Scand J Gastroenterol 1991; 26: 1057-1065.
6. Witteman EM, Mravunac M, Beex MJCM, et al: Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of H. pylori . J Clin Pathol 1995; 48: 250-256.
7. Genta RM, Ginger ML, Graham DY: Changes in the gastric mucosa following eradication of H. pylori. Mod Pathol 1993; 6: 281-289.
8. Hojo M, Miwa H. Ohkusa T, Ohkura R, Kurosawa A, Sato N: Alteration of histological gastritis after cure of H. pylori infection. Aliment Pharmacol Ther 2002; 16: 1923-1932. (Pubitemid 35253008)
9. Nardone G, Rocco A, Malfertheiner P: Helicobacter pylori and molecular events in precancerous gastric lesions. Aliment Pharmacol Ther 2004; 20: 261-270. (Pubitemid 39062128)
10. Wang J, Xu L, Shi R, Huang X, Li S, Huang Z, Zhang G: Gastric atrophy and intestinal metaplasia before and after H. pylori eradication: a meta-analysis. Digestion 2010, in press.
11. McColl KE, El-Omar E, Gillen D, Banerjee S: The role of Helicobacter pylori in the pathophysiology of duodenal ulcer disease and gastric cancer. Semin Gastrointest Dis 1997; 8: 142-155. (Pubitemid 27365854)
12. Correa P, Houghton J: Carcinogenesis of Helicobacter pylori . Gastroenterology 2007; 133: 659-672. (Pubitemid 47187360)
13. Hoffmann W: Regeneration of the gastric mucosa and its glands from stem cells. Curr Med Chem 2008; 15: 3133-3144.
14. El-Zimaity HM, Graham DY: Evaluation of gastric mucosal biopsy site and number for identification of H. pylori or intestinal metaplasia: role of the Sydney System. Hum Pathol 1999; 30: 72-77. (Pubitemid 29037397)
15. Rokkas T, Pistiolas D, Sechopoulos P, Robotis I, Margantinis G: The long-term impact on H. pylori eradication on gastric histology: a systematic review and metaanalysis. Helicobacter 2007; 12(suppl 2): 32-38. (Pubitemid 350076224)
16. Sung JJ, Lin SR, Ching JY, et al: Atrophy and intestinal metaplasia one year after cure of H. pylori infection: a prospective, randomized study. Gastroenterology 2000; 119: 7-14. (Pubitemid 30452573)
17. Ohkusa T, Fujiki K, Takashimizu I, et al: Improvement in atrophic gastritis and intestinal metaplasia in patients in whom H. pylori was eradicated. Ann Intern Med 2001; 134: 380-386. (Pubitemid 32179477)
18. Leung WK, Lin SR, Ching JYL, To KF, Ng EKW, Chan FKL, Lau JYW, Sung JJY: Factors predicting progression of gastric intestinal metaplasia: results of a randomized trial on H. pylori eradication. Gut 2004; 53: 1244-1249. (Pubitemid 39120105)
19. Fukase K, Kato M, Kikuchi S, et al: Effect of eradication of H. pylori on incidence of metachronous gastric carcinoma after endoscopic resection on early gastric cancer: an openlabel, randomized controlled trial. Lancet 2008; 372: 392-397.
20. Malfertheiner P, Megraud F, O'Morain C, Bazzoli F, El-Omar E, Graham D, Hunt R, Rokkas T, Vakil N, Kuipers EJ: Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report. Gut 2007; 56: 772-781. (Pubitemid 46854190)
21. Fock KM, Talley N, Moayyedi P, et al: Asia- Pacific consensus guidelines on gastric cancer prevention. J Gastroenterol Hepatol 2008; 23: 351-365. (Pubitemid 351342074)
22. Asaka M, Kato M, Takahashi S, Fukuda Y, Sugiyama T, Ota H, Uemura N, Murakami K, Satoh K, Sugano K: Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition. Helicobacter 2010; 15(suppl 1): 1-20.
23. de Vries AC, van Grieken NC, Looman CV, et al: Gastric cancer risk in patients with premalignant gastric lesions: a nationwide cohort study in the Netherlands. Gastroenterology 2008; 134: 945-952.